Clesrovimab is a single-dose extended half-life monoclonal antibody developed as a passive immunisation for the prevention of RSV. Credit: Sergiy Palamarchuk ...
The trial demonstrated a median reduction in EEG seizure burden Credit: Ground Picture/Shutterstock. Marinus Pharmaceuticals has reported results from the pivotal Phase III RAISE trial for intravenous ...
Epioxa was developed to be used during the corneal cross-linking procedure to treat keratoconus. Credit: MacroEcon/Shutterstock. Glaukos plans to file for US approval of its iLink corneal ...
The NIH study team says the data supports the safety and quality of the vaccine’s immune response in adolescents. Image credit: Shutterstock/Halfpoint. A clinical ...